C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1992
12/16/1992	EP0517805A1 Identification and expression of insect steroid receptor dna sequences
12/16/1992	EP0517790A1 Method for enhancing recovery of recombinant proteins
12/16/1992	EP0517779A1 SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-$g(b)1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN
12/16/1992	EP0517754A1 Antibody constructs with enhanced binding affinity
12/15/1992	US5171844 For use in treating hemophilia
12/15/1992	US5171841 T-cell suppressor protein
12/15/1992	US5171840 Receptor protein for human B cell stimulatory factor-2
12/15/1992	US5171836 Bactericides for use aganist methicillin-resistant bacteria
12/15/1992	US5171739 Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
12/15/1992	US5171682 Purified Bacillus licheniformis PWD-1 keratinase
12/15/1992	US5171673 Genetic engineering to produce a desired heterologous polypeptides in gram positive bacteria
12/15/1992	US5171670 Recombinant dna method for production of parathyroid hormone
12/15/1992	US5171667 Radiolabeled monoclonal antibodies; diagnosis of cancer
12/15/1992	US5171666 Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas
12/15/1992	US5171665 Monoclonal antibody to novel antigen associated with human tumors
12/15/1992	CA1311430C Construction of an igg binding protein to facilitate downstream processing using protein engineering
12/12/1992	WO1992022654A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	CA2087732A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	CA2071015A1 Immunogenic peptides or polypeptides of the bvd virus and related viruses, vaccines incorporating them or expressing them, methods and means of production thereof
12/10/1992	WO1992021767A1 Me20: monoclonal antibodies and antigen for human melanoma
12/10/1992	WO1992021766A1 Monoclonal antibodies against c-kit
12/10/1992	WO1992021763A1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences
12/10/1992	WO1992021758A1 Mycobacterium proteins and applications
12/10/1992	WO1992021756A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/10/1992	WO1992021754A1 Dna which codes for secretin receptor and polypeptide which is coded for by said dna
12/10/1992	WO1992021753A1 Insecticidal proteins and method for plant protection
12/10/1992	WO1992021751A1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1
12/10/1992	WO1992021699A1 Biocidal proteins
12/10/1992	WO1992021380A1 Method to treat kaposi's sarcoma
12/10/1992	WO1992021374A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments
12/10/1992	WO1992021367A1 T cell receptor peptides as therapeutics for immune-related disease
12/10/1992	WO1992021248A1 Method for production of a whey protein hydrolyzate
12/10/1992	WO1992021240A1 Suppressor t-cell hybridoma
12/10/1992	WO1992017493A3 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
12/10/1992	WO1992014818A3 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
12/10/1992	CA2110687A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments
12/10/1992	CA2110403A1 Biocidal proteins
12/10/1992	CA2110389A1 Mycobacterium proteins and applications
12/10/1992	CA2103365A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/10/1992	CA2103046A1 Suppressor t-cell hybridoma
12/09/1992	EP0517024A2 Tetravalent bispecific receptors, their preparation and use
12/09/1992	EP0516863A1 ANTIBODY AGAINST HUMAN PLASMIN-$g(a) 2?-PLASMIN INHIBITOR COMPLEX, HYBRIDOMA AND IMMUNOASSAY
12/09/1992	EP0516787A1 Expression systems
12/09/1992	EP0516721A1 Antigenic proteins of plasmodium
12/09/1992	EP0516655A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine.
12/09/1992	CN1019355B Process for minactivin and its use
12/08/1992	US5169941 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto
12/08/1992	US5169930 Integrin with preferential binding to fibronectin not vitronectin
12/08/1992	US5169840 Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
12/08/1992	US5169836 Inhibitors of platelet binding
12/08/1992	US5169835 Pregancy specific proteins applications
12/08/1992	US5169775 React with canin lympohma cells and not with normal canine lymphocytes
12/08/1992	US5169764 Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
12/08/1992	US5169761 Dna encoding and expression systems for alveolar surfactant proteins
12/08/1992	US5169760 Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
12/08/1992	US5169629 Process of controlling lepidopteran pests, using bacillus thuringiensis isolate denoted b.t ps81gg
12/08/1992	US5169628 Vaccines
12/08/1992	CA1311203C Dipeptidase, its isolation from lactic acid bacteria, antibodies against the dipeptidase, the use of the dipeptidase and of the antibodies against it
12/08/1992	CA1311192C Tumor specific assay for ca125 ovarian cancer antigen
12/07/1992	WO1992021759A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof
12/07/1992	WO1992021375A1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
12/07/1992	CA2088666A1 Nucleotide and peptide sequences of hepatitis c virus isolate, diagnostic and therapeutic applications
12/04/1992	WO1992021979A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/04/1992	CA2103142A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/04/1992	CA2070233A1 Tetravalent bispecific receptors, the preparation and use thereof
12/02/1992	EP0516306A2 Novel bacillus thuringiensis isolates active against hymenopteran pests and gene(s) encoding hymenopteran-active toxins
12/02/1992	EP0516286A1 Hepatitis B virus surface proteins with reduced host carbohydrate content
12/02/1992	EP0516190A2 Monoclonal antibodies, process for preparing them and their use
12/02/1992	EP0516135A2 Human immunodeficiency virus-related immune preparation
12/02/1992	EP0515571A1 Hybrid reagents capable of selectively releasing molecules into cells
12/02/1992	EP0515569A1 Calcium channel compositions and methods
12/02/1992	EP0515554A1 Method for generating and screening useful peptides.
12/02/1992	EP0515516A1 Totally synthetic affinity reagents
12/02/1992	EP0515394A1 COVALENT ANGIOGENIN/RNase HYBRIDS
12/02/1992	EP0496833A4 Biosynthetic constructs of tgf--g(b)
12/02/1992	CN1019267B Synthetic vaccines for foot and mounth disease
12/01/1992	WO1992021755A1 Treatment of hiv-associated immune thrombocytopenic purpura
12/01/1992	US5168063 Strong binding of outer membrane protein; medical diagnosis
12/01/1992	US5168050 DNA constructs, mammalian expression vectors and host cells containing same
12/01/1992	US5168049 Production of streptavidin-like polypeptides
12/01/1992	US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
12/01/1992	US5168044 Capturing neutrophils or fragments or soluble products thereof in milk on insolubilized form of antibody
12/01/1992	CA2108580A1 Treatment of hiv-associated immune thrombocytopenic purpura
12/01/1992	CA2069671A1 Human immunodeficiency virus-related immune preparation
12/01/1992	CA1310924C Infective drug delivery system
12/01/1992	CA1310923C Dna encoding [asp --] and [lys -, asp --] thaumatin i
12/01/1992	CA1310922C Vaccine to control the viral infection of fish
12/01/1992	CA1310921C Vector for the expression of fusion proteins and protein immunogens
12/01/1992	CA1310902C Autocrine motility factors in cancer diagnosis and management
11/1992
11/26/1992	WO1992021029A1 Selecting ligand agonists and antagonists
11/26/1992	WO1992020807A1 Plant defense gene(s) and regulatory element(s)
11/26/1992	WO1992020806A2 Dictyostelid expression vector and method for expressing a desired protein
11/26/1992	WO1992020803A1 THE ASTROVIRUS HUMAN GASTROENTERITIS AGENTS AND MOLECULAR CLONING OF CORRESPONDING cDNAs
11/26/1992	WO1992020801A1 Novel antipathogenic peptides and compositions containing same
11/26/1992	WO1992020799A1 Amino acid sequence of anticancer human monoclonal antibody and dna base sequence coding for the same
11/26/1992	WO1992020798A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2¿
11/26/1992	WO1992020797A1 Neurotrophic factor, preparation and uses thereof
11/26/1992	WO1992020796A2 D-type cyclin and uses related thereto
11/26/1992	WO1992020795A1 INHIBITOR OF NF-λB TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF
11/26/1992	WO1992020794A1 Purification and cloning of p62

1 ... 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 ... 1125